158 related articles for article (PubMed ID: 22234107)
21. [Branhamella catarrhalis in respiratory infections].
Marín Casanova P; García-Martos P; Fernández Fatou B; Bernal García F; Agudo Pérez E
Rev Clin Esp; 1989 May; 184(8):399-400. PubMed ID: 2506614
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial susceptibility of Moraxella catarrhalis isolated from children in Kalgoorlie-Boulder, Western Australia.
Pingault NM; Bowman JM; Lehmann D; Riley TV
Pathology; 2010 Apr; 42(3):273-9. PubMed ID: 20350222
[TBL] [Abstract][Full Text] [Related]
23. Bronchopulmonary infection due to Moraxella (Branhamella) catarrhalis at a specialist hospital in Saudi Arabia.
Ahmad S
J Commun Dis; 1998 Dec; 30(4):233-6. PubMed ID: 10810561
[TBL] [Abstract][Full Text] [Related]
24. Clinical and laboratory aspects of Moraxella catarrhalis bacteremia in children.
Ahmed A; Broides A; Givon-Lavi N; Peled N; Dagan R; Greenberg D
Pediatr Infect Dis J; 2008 May; 27(5):459-61. PubMed ID: 18360302
[TBL] [Abstract][Full Text] [Related]
25. β-Lactamase production and antibiotic susceptibility pattern of Moraxella catarrhalis isolates collected from two county hospitals in China.
Shi W; Wen D; Chen C; Yuan L; Gao W; Tang P; Cheng X; Yao K
BMC Microbiol; 2018 Jul; 18(1):77. PubMed ID: 30029595
[TBL] [Abstract][Full Text] [Related]
26. [Clinical, diagnostic and therapeutic aspects of Moraxella catarrhalis infections].
Bourgeois F; Lambert-Zechovsky N; Bingen E
Pathol Biol (Paris); 1993 Jun; 41(6):555-61. PubMed ID: 8247636
[TBL] [Abstract][Full Text] [Related]
27. [Antibiotic resistance and the detection in respiratory tract isolate of Moraxella catarrhalis].
Yao DM; Hong M; Tong MH
Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):88-9. PubMed ID: 12934414
[No Abstract] [Full Text] [Related]
28. [Molecular characterization of BRO beta-lactamases of Moraxella catarrhalis strains isolated from carrier children].
Köseoğlu O; Ergin A; Gürkan Aydin N; Hasçelik G
Mikrobiyol Bul; 2004 Oct; 38(4):335-40. PubMed ID: 15700658
[TBL] [Abstract][Full Text] [Related]
29. Moraxella (Branhamella) catarrhalis--clinical and molecular aspects of a rediscovered pathogen.
Enright MC; McKenzie H
J Med Microbiol; 1997 May; 46(5):360-71. PubMed ID: 9152030
[TBL] [Abstract][Full Text] [Related]
30. Determination of the antimicrobial susceptibilities of Canadian isolates of Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis. Canadian Antimicrobial Study Group.
Blondeau JM; Suter M; Borsos S
J Antimicrob Chemother; 1999 Mar; 43 Suppl A():25-30. PubMed ID: 10225568
[TBL] [Abstract][Full Text] [Related]
31. Tracking resistance among bacterial respiratory tract pathogens: summary of findings of the TRUST Surveillance Initiative, 2001-2005.
Sahm DF; Brown NP; Draghi DC; Evangelista AT; Yee YC; Thornsberry C
Postgrad Med; 2008 Sep; 120(3 Suppl 1):8-15. PubMed ID: 18931466
[TBL] [Abstract][Full Text] [Related]
32. [Antimicrobial susceptibility of 80 Moraxella catarrhalis strains isolated in the children's hospital of Tunis].
Khemiri H; Smaoui H; Kechrid A
Pathol Biol (Paris); 2008 May; 56(3):158-61. PubMed ID: 18178028
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
Esel D; Ay-Altintop Y; Yagmur G; Gokahmetoglu S; Sumerkan B
Clin Microbiol Infect; 2007 Oct; 13(10):1023-5. PubMed ID: 17608812
[TBL] [Abstract][Full Text] [Related]
34. [Branhamella catarrhalis: incidence in pulmonary infections and determination of sensitivity to 5 antibiotics].
Texier-Maugein J; Escoubas J; Fouche J; Mormede M
Pathol Biol (Paris); 1988 May; 36(5):540-3. PubMed ID: 3136431
[TBL] [Abstract][Full Text] [Related]
35. Antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and group A beta-haemolytic streptococci in 2002-2003. Results of the multinational GRASP Surveillance Program.
Beekmann SE; Heilmann KP; Richter SS; García-de-Lomas J; Doern GV;
Int J Antimicrob Agents; 2005 Feb; 25(2):148-56. PubMed ID: 15664485
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98).
Sader HS; Gales AC; Granacher TD; Pfaller MA; Jones RN;
Braz J Infect Dis; 2000 Oct; 4(5):245-54. PubMed ID: 11063556
[TBL] [Abstract][Full Text] [Related]
37. High-Level Macrolide-Resistant Moraxella catarrhalis and Development of an Allele-Specific PCR Assay for Detection of 23S rRNA Gene A2330T Mutation: A Three-Year Study at a Chinese Tertiary Hospital.
Liu Y; Xu H; Xu Z; Kudinha T; Fan X; Xiao M; Kong F; Sun H; Xu Y
Microb Drug Resist; 2015 Oct; 21(5):507-11. PubMed ID: 25923017
[TBL] [Abstract][Full Text] [Related]
38. Global and local variations in antimicrobial susceptibilities and resistance development in the major respiratory pathogens.
Alpuche C; Garau J; Lim V
Int J Antimicrob Agents; 2007 Dec; 30 Suppl 2():S135-8. PubMed ID: 17945468
[TBL] [Abstract][Full Text] [Related]
39. Distribution of genes encoding virulence factors ompB2, ompCD, ompE, β-lactamase and serotype in pathogenic and colonizing strains of Moraxella catarrhalis.
Mitov IG; Gergova RT; Ouzounova-Raykova VV
Arch Med Res; 2010 Oct; 41(7):530-5. PubMed ID: 21167392
[TBL] [Abstract][Full Text] [Related]
40. PROTEKT 1999-2000: a multicentre study of the antimicrobial susceptibility of respiratory tract pathogens in Japan.
Inoue M; Kohno S; Kaku M; Yamaguchi K; Igari J; Yamanaka K
Int J Infect Dis; 2005 Jan; 9(1):27-36. PubMed ID: 15603993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
